163
Views
13
CrossRef citations to date
0
Altmetric
Original Article

Antipsychotic switching: results from a one-year prospective, observational study of patients with schizophrenia

, , , , , , , & show all
Pages 2121-2132 | Accepted 09 Jun 2009, Published online: 14 Jul 2009

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (2)

Hasan Karadag, Sibel Orsel, Serkan Akkoyunlu, Akfer Karaoglan Kahilogulları, Olga Guriz, Hakan Turkcapar & Ugur Hatiloglu. (2012) Comparison of Polypharmacy in Schizophrenia and Other Psychotic Disorders in Outpatient and Inpatient Treatment Periods: A Naturalistic One Year Follow-up Study. Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology 22:2, pages 130-138.
Read now
Katarina Kelin, Timothy JR Lambert, Alan JM Brnabic, Richard Newton, Wendy Ye, Raúl I Escamilla, Kuang-Peng Chen, Liana Don, William Montgomery, Jamie Karagianis & Haya Ascher-Svanum. (2011) Treatment discontinuation and clinical outcomes in the 1-year naturalistic treatment of patients with schizophrenia at risk of treatment nonadherence. Patient Preference and Adherence 5, pages 213-222.
Read now

Articles from other publishers (11)

Carla Rognoni, Arianna Bertolani & Claudio Jommi. (2021) Second-Generation Antipsychotic Drugs for Patients with Schizophrenia: Systematic Literature Review and Meta-analysis of Metabolic and Cardiovascular Side Effects. Clinical Drug Investigation 41:4, pages 303-319.
Crossref
Takahiro Masuda, Fuminari Misawa, Masayuki Takase, John M. Kane & Christoph U. Correll. (2019) Association With Hospitalization and All-Cause Discontinuation Among Patients With Schizophrenia on Clozapine vs Other Oral Second-Generation Antipsychotics. JAMA Psychiatry 76:10, pages 1052.
Crossref
Cvetka Bačar Bole, Mitja Pišlar, Metka Šen, Rok Tavčar & Aleš Mrhar. (2017) Switching antipsychotics: Results of 16-month non-interventional, prospective, observational clinical research of inpatients with schizophrenia spectrum disorders. Acta Pharmaceutica 67:1, pages 99-112.
Crossref
Gregory Kruse, Bruce J. O. Wong, Mei Sheng Duh, Patrick Lefebvre, Marie-Hélène Lafeuille & John M. Fastenau. (2015) Systematic Literature Review of the Methods Used to Compare Newer Second-Generation Agents for the Management of Schizophrenia: A focus on Health Technology Assessment. PharmacoEconomics 33:10, pages 1049-1067.
Crossref
Maarten Bak, Annemarie Fransen, Jouke Janssen, Jim van Os & Marjan Drukker. (2014) Almost All Antipsychotics Result in Weight Gain: A Meta-Analysis. PLoS ONE 9:4, pages e94112.
Crossref
Andreas Roussidis, Christina Kalkavoura, Dimos Dimelis, Afroditi Theodorou, Ina Ioannidou, Eleytherios Mellos, Triantafyllia Mylonaki, Areti Spyropoulou & Andreas Yfantis. (2013) Reasons and clinical outcomes of antipsychotic treatment switch in outpatients with schizophrenia in real-life clinical settings: the ETOS observational study. Annals of General Psychiatry 12:1, pages 42.
Crossref
Dimitrios Kontis & Eirini Theochari. 2013. Polypharmacy in Psychiatry Practice, Volume I. Polypharmacy in Psychiatry Practice, Volume I 75 105 .
Miguel Bernardo, Anna Coma, Cristina Ibáñez, Corinne Zara, Josep Maria Bari & Antoni Serrano-Blanco. (2012) Antipsychotic polypharmacy in a regional health service: a population-based study. BMC Psychiatry 12:1.
Crossref
A. J. M. Brnabic, K. Kelin, H. Ascher-Svanum, W. Montgomery, Z. Kadziola & J. Karagianis. (2011) Medication discontinuation with depot and oral antipsychotics in outpatients with schizophrenia: comparison of matched cohorts from a 12-month observational study. International Journal of Clinical Practice 65:9, pages 945-953.
Crossref
Jamie Karagianis & Angela Hill. (2010) Schizophrenia in a worldwide perspective: explaining similarities and differences. Future Neurology 5:3, pages 345-348.
Crossref
Franca Centorrino, Antonio Ventriglio, Alessio Vincenti, Alessandra Talamo & Ross J. Baldessarini. (2010) Changes in medication practices for hospitalized psychiatric patients: 2009 versus 2004. Human Psychopharmacology: Clinical and Experimental 25:2, pages 179-186.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.